Literature DB >> 25107531

MAGE proteins regulate KRAB zinc finger transcription factors and KAP1 E3 ligase activity.

Tony Z Xiao1, Yewseok Suh2, B Jack Longley3.   

Abstract

Expression of Melanoma AntiGen Encoding (MAGE) genes, particularly MAGE-A3, has been correlated with aggressive clinical course, the acquisition of resistance to chemotherapy and poor clinical outcomes of melanoma and other malignancies. MAGE proteins bind to KAP1, a gene repressor and ubiquitin E3 ligase which also binds KRAB domain containing zinc finger transcription factors (KZNFs), and MAGE expression may affect KZNF mediated gene regulation. To investigate mechanisms for these effects, we tested the hypothesis that differences in KRAB domain composition affect KZNF poly-ubiquitination and determine whether MAGE expression increases, decreases, or has no effect on KZNFs mediated gene repression. Using an integrated reporter gene responsive to repression by KRAB domain fusion proteins, we found that MAGE-A3 relieved KZNF mediated repression and induced KZNF poly-ubiquitination and degradation in association with expression of the A+B box KRAB domain. In contrast, MAGE-A3 enhanced KAP1 mediated repression of KZNFs expressing A or A+b box KRAB domains but caused no increase in poly-ubiquitination or degradation. MAGE-A3 has no significant impact on KZNFs with KRAB domains containing the Scan box motif. These data support our hypothesis by showing that the effects of MAGE-A3 on gene repression depend on the type of KZNF KRAB domain involved.

Entities:  

Keywords:  KRAB; MAGE; Melanoma; ZNF

Mesh:

Substances:

Year:  2014        PMID: 25107531      PMCID: PMC4221552          DOI: 10.1016/j.abb.2014.07.026

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  35 in total

1.  Sequence-specific transcriptional repression by KS1, a multiple-zinc-finger-Krüppel-associated box protein.

Authors:  B Gebelein; R Urrutia
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

2.  An overview of the MAGE gene family with the identification of all human members of the family.

Authors:  P Chomez; O De Backer; M Bertrand; E De Plaen; T Boon; S Lucas
Journal:  Cancer Res       Date:  2001-07-15       Impact factor: 12.701

3.  Co-expression of granulocyte-macrophage colony-stimulating factor with antigen enhances humoral and tumor immunity after DNA vaccination.

Authors:  Xiangle Sun; Lisa M Hodge; Harlan P Jones; Leslie Tabor; Jerry W Simecka
Journal:  Vaccine       Date:  2002-01-31       Impact factor: 3.641

Review 4.  The RB and p53 pathways in cancer.

Authors:  Charles J Sherr; Frank McCormick
Journal:  Cancer Cell       Date:  2002-08       Impact factor: 31.743

5.  Overexpression of MAGE/GAGE genes in paclitaxel/doxorubicin-resistant human cancer cell lines.

Authors:  Zhenfeng Duan; Yifei Duan; Diana E Lamendola; Rushdia Z Yusuf; Rizwan Naeem; Richard T Penson; Michael V Seiden
Journal:  Clin Cancer Res       Date:  2003-07       Impact factor: 12.531

6.  A new strategy for the diagnosis of MAGE-expressing cancers.

Authors:  Jong Wook Park; Taeg Kyu Kwon; In Ho Kim; Soo Sang Sohn; You Sah Kim; Chun Il Kim; Ok Suk Bae; Kyung Seop Lee; Kang Dae Lee; Cheong Sam Lee; Hee Kyung Chang; Byung Kil Choe; Su Yul Ahn; Chang Ho Jeon
Journal:  J Immunol Methods       Date:  2002-08-01       Impact factor: 2.303

Review 7.  Cytolytic T-cell responses of cancer patients vaccinated with a MAGE antigen.

Authors:  Pierre G Coulie; Vaios Karanikas; Christophe Lurquin; Didier Colau; Thierry Connerotte; Takeshi Hanagiri; Aline Van Pel; Sophie Lucas; Danièle Godelaine; Christophe Lonchay; Marie Marchand; Nicolas Van Baren; Thierry Boon
Journal:  Immunol Rev       Date:  2002-10       Impact factor: 12.988

Review 8.  Dendritic cells in vaccination therapies of malignant diseases.

Authors:  Peter Brossart; Peter Brossart M D
Journal:  Transfus Apher Sci       Date:  2002-10       Impact factor: 1.764

9.  A MAGE-3 peptide presented by HLA-DR1 to CD4+ T cells that were isolated from a melanoma patient vaccinated with a MAGE-3 protein.

Authors:  Yi Zhang; Pascal Chaux; Vincent Stroobant; Alexander M M Eggermont; Jurgen Corthals; Bernard Maillère; Kris Thielemans; Marie Marchand; Thierry Boon; Pierre Van Der Bruggen
Journal:  J Immunol       Date:  2003-07-01       Impact factor: 5.422

10.  Mice lacking the transcriptional corepressor TIF1beta are defective in early postimplantation development.

Authors:  F Cammas; M Mark; P Dollé; A Dierich; P Chambon; R Losson
Journal:  Development       Date:  2000-07       Impact factor: 6.868

View more
  9 in total

Review 1.  Cellular and disease functions of the Prader-Willi Syndrome gene MAGEL2.

Authors:  Klementina Fon Tacer; Patrick Ryan Potts
Journal:  Biochem J       Date:  2017-06-16       Impact factor: 3.857

Review 2.  A Comprehensive Guide to the MAGE Family of Ubiquitin Ligases.

Authors:  Anna K Lee; Patrick Ryan Potts
Journal:  J Mol Biol       Date:  2017-03-11       Impact factor: 5.469

Review 3.  Emerging roles of the MAGE protein family in stress response pathways.

Authors:  Rebecca R Florke Gee; Helen Chen; Anna K Lee; Christina A Daly; Benjamin A Wilander; Klementina Fon Tacer; Patrick Ryan Potts
Journal:  J Biol Chem       Date:  2020-09-13       Impact factor: 5.157

Review 4.  The MAGE protein family and cancer.

Authors:  Jenny L Weon; Patrick Ryan Potts
Journal:  Curr Opin Cell Biol       Date:  2015-09-03       Impact factor: 8.382

5.  Structures of Two Melanoma-Associated Antigens Suggest Allosteric Regulation of Effector Binding.

Authors:  Joseph A Newman; Christopher D O Cooper; Anette K Roos; Hazel Aitkenhead; Udo C T Oppermann; Hearn J Cho; Roman Osman; Opher Gileadi
Journal:  PLoS One       Date:  2016-02-24       Impact factor: 3.240

6.  ZNF224, Krüppel like zinc finger protein, induces cell growth and apoptosis-resistance by down-regulation of p21 and p53 via miR-663a.

Authors:  Jin Gu Cho; Seho Park; Chae Hyun Lim; Hong Sook Kim; Seung Yong Song; Tae-Young Roh; Jong-Hyuk Sung; Wonhee Suh; Seok-Jin Ham; Key-Hwan Lim; Sang Gyu Park
Journal:  Oncotarget       Date:  2016-05-24

7.  Generation of TRIM28 Knockout K562 Cells by CRISPR/Cas9 Genome Editing and Characterization of TRIM28-Regulated Gene Expression in Cell Proliferation and Hemoglobin Beta Subunits.

Authors:  Yao-Jen Chang; Zhifu Kang; Jiayuan Bei; Shu-Jen Chou; Mei-Yeh Jade Lu; Yu-Lun Su; Sheng-Wei Lin; Hsin-Hui Wang; Steven Lin; Ching-Jin Chang
Journal:  Int J Mol Sci       Date:  2022-06-20       Impact factor: 6.208

8.  Tumor suppressive miR-6775-3p inhibits ESCC progression through forming a positive feedback loop with p53 via MAGE-A family proteins.

Authors:  Lingjiao Meng; Fei Liu; Yingchao Ju; Pingan Ding; Sihua Liu; Sheng Chang; Shina Liu; Yi Zhang; Yishui Lian; Lina Gu; Xiaochong Zhang; Meixiang Sang
Journal:  Cell Death Dis       Date:  2018-10-17       Impact factor: 8.469

9.  Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinoma.

Authors:  Amanda J Craig; Teresa Garcia-Lezana; Marina Ruiz de Galarreta; Carlos Villacorta-Martin; Edgar G Kozlova; Sebastiao N Martins-Filho; Johann von Felden; Mehmet Eren Ahsen; Erin Bresnahan; Gabriela Hernandez-Meza; Ismail Labgaa; Delia D'Avola; Myron Schwartz; Josep M Llovet; Daniela Sia; Swan Thung; Bojan Losic; Amaia Lujambio; Augusto Villanueva
Journal:  PLoS Genet       Date:  2021-06-24       Impact factor: 5.917

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.